Therapeutic potential of an indole derivative in fatal fibrosing interstitial lung diseases

被引：0
|
作者：
Yoon, Yeogha [1 ]
Kim, Wankyu [1 ]
Park, Hae Jin [2 ,3 ]
Park, Kyung Hwa [2 ,3 ]
Kim, So Ri [2 ,3 ]
Choe, Yeong Hun [2 ,3 ]
Jeong, Jae Seok [2 ,3 ]
Lee, Yong Chul [2 ,3 ]
机构：
[1] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea
[2] Jeonbuk Natl Univ, Dept Internal Med, Res Ctr Pulm Disorders, Sch Med, Jeonju, South Korea
[3] Jeonbuk Natl Univ, Biomed Res Inst, Res Inst Clin Med, Jeonbuk Natl Univ Hosp, Jeonju, South Korea
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO03-6
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [1] KL-6 as a potential therapeutic biomarker in fibrosing interstitial lung diseases
    Somogyi, Vivien
    Mayer, Katharina
    Kriegsmann, Katharina
    Kriegsmann, Mark
    Findeisen, Peter
    Kreuter, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [2] Therapeutic Potential of an Indole Derivative in Fatal Environmental Compound-induced Lung Injury
    Jeong, J.
    Kim, S.
    Park, H.
    Park, K.
    Lee, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
    Wollin, Lutz
    Distler, Joerg H. W.
    Redente, Elizabeth F.
    Riches, David W. H.
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Maher, Toby M.
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (03)
  • [4] Management of Fibrosing Interstitial Lung Diseases
    Maher, Toby M.
    Wuyts, Wim
    ADVANCES IN THERAPY, 2019, 36 (07) : 1518 - 1531
  • [5] Management of Fibrosing Interstitial Lung Diseases
    Toby M. Maher
    Wim Wuyts
    Advances in Therapy, 2019, 36 : 1518 - 1531
  • [6] Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
    Cottin, Vincent
    EUROPEAN RESPIRATORY REVIEW, 2019, 28 (153):
  • [7] Management of patients with fibrosing interstitial lung diseases
    Morrow, Lee E.
    Hilleman, Daniel
    Malesker, Mark A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (03) : 129 - 139
  • [8] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Kao, Jui-Hung
    Huang, Hsin-Tuan
    Li, Ko-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 781
  • [9] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
  • [10] Fibrosing interstitial lung diseases: knowns and unknowns
    Cottin, Vincent
    Wollin, Lutz
    Fischer, Aryeh
    Quaresma, Manuel
    Stowasser, Susanne
    Harari, Sergio
    EUROPEAN RESPIRATORY REVIEW, 2019, 28 (151):
12345